Company Description

Mandos Health, a wholly-owned subsidiary of Beren Therapeutics Public Benefit Corporation (P.B.C.), a biotechnology company committed to the development of adrabetadex for individuals living with Niemann-Pick Disease Type C (NPC), a condition characterized by defects in cholesterol trafficking.